These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 25340589)
1. Dynamic contrast-enhanced magnetic resonance imaging for pancreatic ductal adenocarcinoma at 3.0-T magnetic resonance: correlation with histopathology. Liu K; Xie P; Peng W; Zhou Z J Comput Assist Tomogr; 2015; 39(1):13-8. PubMed ID: 25340589 [TBL] [Abstract][Full Text] [Related]
2. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions. Liu K; Xie P; Peng W; Zhou Z J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of pancreatic cancer by multiple breath-hold dynamic contrast-enhanced magnetic resonance imaging at 3.0T. Yao X; Zeng M; Wang H; Sun F; Rao S; Ji Y Eur J Radiol; 2012 Aug; 81(8):e917-22. PubMed ID: 22695786 [TBL] [Abstract][Full Text] [Related]
4. The effect of gadolinium chelate contrast agent on diffusion-weighted imaging of pancreatic ductal adenocarcinoma. Liu K; Peng W; Zhou Z Acta Radiol; 2013 May; 54(4):364-8. PubMed ID: 23386737 [TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055 [TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images. Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783 [TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model. Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study. Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy. Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976 [TBL] [Abstract][Full Text] [Related]
10. The Correlation Between Diffusion-Weighted Imaging at 3.0-T Magnetic Resonance Imaging and Histopathology for Pancreatic Ductal Adenocarcinoma. Xie P; Liu K; Peng W; Zhou Z J Comput Assist Tomogr; 2015; 39(5):697-701. PubMed ID: 26176427 [TBL] [Abstract][Full Text] [Related]
11. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study. Mendichovszky IA; Cutajar M; Gordon I Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588 [TBL] [Abstract][Full Text] [Related]
12. Liver dynamic contrast-enhanced MRI for staging liver fibrosis in a piglet model. Zhou L; Chen TW; Zhang XM; Yang Z; Tang HJ; Deng D; Zeng NL; Wang LY; Chen XL; Li H; Li CP; Li L; Xie XY; Hu J J Magn Reson Imaging; 2014 Apr; 39(4):872-8. PubMed ID: 24123400 [TBL] [Abstract][Full Text] [Related]
13. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content. Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159 [TBL] [Abstract][Full Text] [Related]
14. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI. Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002 [TBL] [Abstract][Full Text] [Related]
16. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results. Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200 [TBL] [Abstract][Full Text] [Related]
17. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab. Hsu YH; Ferl GZ; Ng CM Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680 [TBL] [Abstract][Full Text] [Related]
18. Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Pancreatic Cancer: Characteristics and Correlation With Histopathologic Parameters. Ma W; Li N; Zhao W; Ren J; Wei M; Yang Y; Wang Y; Fu X; Zhang Z; Larson AC; Huan Y J Comput Assist Tomogr; 2016; 40(5):709-16. PubMed ID: 27224231 [TBL] [Abstract][Full Text] [Related]
19. Computer-aided diagnosis of breast DCE-MRI using pharmacokinetic model and 3-D morphology analysis. Wang TC; Huang YH; Huang CS; Chen JH; Huang GY; Chang YC; Chang RF Magn Reson Imaging; 2014 Apr; 32(3):197-205. PubMed ID: 24439361 [TBL] [Abstract][Full Text] [Related]
20. Comparison of quantitative and semiquantitative dynamic contrast-enhanced MRI with respect to their correlation to delayed gadolinium-enhanced MRI of the cartilage in patients with early rheumatoid arthritis. Müller-Lutz A; Schleich C; Sewerin P; Gross J; Pentang G; Wittsack HJ; Antoch G; Schneider M; Ostendorf B; Miese F J Comput Assist Tomogr; 2015; 39(1):64-9. PubMed ID: 25340588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]